BioCina aims for vaccines against biowarfare threats

Pharmaceutical and vaccine manufacturer BioCina is industry partner in an ambitious research project that aims to develop vaccine candidates to protect against biowarfare threats including Q Fever, tularaemia, and melioidosis. BioCina, the health Security Systems Australia (HSSA) division of defence innovation group DMTC, and academics led by Griffith University, including the Australian Rickettsial Reference Laboratory…

Genetic Signatures prepares to launch parasite test kits in the US

Molecular diagnostic company Genetic Signatures has submitted an application seeking US Food and Drug Administration approval for its EasyScreen Gastrointestinal Parasite Detection Kit. The easy to use kit aims to replace current screening methods which involve sample culturing and microscopic inspection, antigen detection and pathogen-specific molecular tests, Genetic Signatures said the US market for the…